Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 466

1.

Measles: Breakouts and Breakthroughs.

Plotkin SA.

J Pediatric Infect Dis Soc. 2019 Sep 25;8(4):289-290. doi: 10.1093/jpids/piz043. No abstract available.

PMID:
31282536
2.

How to Prepare for Expert Testimony on the Safety of Vaccination.

Plotkin SA.

Pediatrics. 2019 Apr;143(4). pii: e20183578. doi: 10.1542/peds.2018-3578. Epub 2019 Mar 6. No abstract available.

PMID:
30842258
3.

Chikungunya Virus: A Back-Breaking Problem.

Plotkin SA.

J Pediatric Infect Dis Soc. 2019 May 11;8(2):95-96. doi: 10.1093/jpids/piz012. No abstract available.

PMID:
30840767
4.

Dengue Vaccine, A Double-Edged Sword.

Plotkin SA.

J Pediatric Infect Dis Soc. 2019 Jan 18. doi: 10.1093/jpids/piy140. [Epub ahead of print] No abstract available.

PMID:
30657941
5.

The National Vaccine Injury Compensation Program: Striking a Balance Between Individual Rights and Community Benefit.

Meissner HC, Nair N, Plotkin SA.

JAMA. 2019 Jan 29;321(4):343-344. doi: 10.1001/jama.2018.20421. No abstract available.

PMID:
30608524
6.

Ten yearly yellow fever booster vaccinations may still be justified.

Plotkin SA.

J Travel Med. 2018 Jan 1;25(1). doi: 10.1093/jtm/tay130. No abstract available.

PMID:
30462249
7.

Important New Resource for Clinicians Giving Expert Witness Testimony on Vaccines.

Plotkin SA, Offit PA, Reiss D.

Pediatr Infect Dis J. 2018 Dec;37(12):e353. doi: 10.1097/INF.0000000000002210. No abstract available.

PMID:
30408015
8.

Lemons and Lyme.

Plotkin SA.

J Pediatric Infect Dis Soc. 2018 Dec 3;7(4):267-269. doi: 10.1093/jpids/piy083. No abstract available.

PMID:
30212842
9.

Composition of pertussis vaccine given to infants determines long-term T cell polarization.

Plotkin SA.

J Clin Invest. 2018 Aug 31;128(9):3742-3744. doi: 10.1172/JCI122726. Epub 2018 Aug 6.

10.

Reply to Gantt et al., "Higher Expectations for a Vaccine To Prevent Congenital Cytomegalovirus Infection".

Permar SR, Schleiss MR, Plotkin SA.

J Virol. 2018 Jul 17;92(15). pii: e00771-18. doi: 10.1128/JVI.00771-18. Print 2018 Aug 1. No abstract available.

11.

The Influenza Vaccine Mess.

Plotkin SA.

J Pediatric Infect Dis Soc. 2018 Aug 17;7(3):178-180. doi: 10.1093/jpids/piy057. No abstract available.

PMID:
29982613
12.

Portait of an ISV fellow.

Plotkin SA.

Hum Vaccin Immunother. 2018;14(8):1836-1839. doi: 10.1080/21645515.2018.1480199. Epub 2018 Jun 22. No abstract available.

13.

Seroconversion for Cytomegalovirus Infection During Pregnancy and Fetal Infection in a Highly Seropositive Population: "The BraCHS Study," by Mussi-Pinhata et al.

Plotkin SA.

J Infect Dis. 2018 Sep 8;218(8):1188-1190. doi: 10.1093/infdis/jiy322. No abstract available.

PMID:
29868893
14.

Mumps: A Pain in the Neck.

Plotkin SA.

J Pediatric Infect Dis Soc. 2018 May 15;7(2):91-92. doi: 10.1093/jpids/piy038. No abstract available.

PMID:
29718326
15.

Vaccination against the human cytomegalovirus.

Plotkin SA, Boppana SB.

Vaccine. 2018 Apr 2. pii: S0264-410X(18)30288-3. doi: 10.1016/j.vaccine.2018.02.089. [Epub ahead of print]

16.

Case 4-2018: A Newborn with Thrombocytopenia, Cataracts, and Hepatosplenomegaly.

Baltimore RS, Nimkin K, Sparger KA, Pierce VM, Plotkin SA.

N Engl J Med. 2018 Feb 8;378(6):564-572. doi: 10.1056/NEJMcpc1706110. No abstract available.

PMID:
29414276
17.

Vaccine mandates in France will save lives.

Plotkin SA, Offit P, Bégué P.

Science. 2018 Jan 19;359(6373):283-284. doi: 10.1126/science.aar4422. No abstract available.

PMID:
29348229
18.

Advancing Our Understanding of Protective Maternal Immunity as a Guide for Development of Vaccines To Reduce Congenital Cytomegalovirus Infections.

Permar SR, Schleiss MR, Plotkin SA.

J Virol. 2018 Mar 14;92(7). pii: e00030-18. doi: 10.1128/JVI.00030-18. Print 2018 Apr 1. Review.

19.

Third Dose of MMR Vaccine for Mumps Control.

Plotkin SA.

N Engl J Med. 2017 Dec 14;377(24):2403. doi: 10.1056/NEJMc1714219. No abstract available.

PMID:
29236638
20.

Vaccines We Need But Don't Have.

Plotkin SA.

Viral Immunol. 2018 Mar;31(2):114-116. doi: 10.1089/vim.2017.0126. Epub 2017 Nov 13. Review.

PMID:
29131713
21.

Progress toward Development of a Vaccine against Congenital Cytomegalovirus Infection.

Schleiss MR, Permar SR, Plotkin SA.

Clin Vaccine Immunol. 2017 Dec 5;24(12). pii: e00268-17. doi: 10.1128/CVI.00268-17. Print 2017 Dec. Review.

22.

Whither vaccines?

Rodrigues CMC, Pinto MV, Sadarangani M, Plotkin SA.

J Infect. 2017 Jun;74 Suppl 1:S2-S9. doi: 10.1016/S0163-4453(17)30184-6. Review.

PMID:
28646957
23.

Waning Immunity and Microbial Vaccines-Workshop of the National Institute of Allergy and Infectious Diseases.

Gu XX, Plotkin SA, Edwards KM, Sette A, Mills KHG, Levy O, Sant AJ, Mo A, Alexander W, Lu KT, Taylor CE.

Clin Vaccine Immunol. 2017 Jul 5;24(7). pii: e00034-17. doi: 10.1128/CVI.00034-17. Print 2017 Jul.

24.

Vaccines for epidemic infections and the role of CEPI.

Plotkin SA.

Hum Vaccin Immunother. 2017 Dec 2;13(12):2755-2762. doi: 10.1080/21645515.2017.1306615. Epub 2017 Apr 4. Review.

25.

What Is Wrong with Pertussis Vaccine Immunity? The Problem of Waning Effectiveness of Pertussis Vaccines.

Burdin N, Handy LK, Plotkin SA.

Cold Spring Harb Perspect Biol. 2017 Dec 1;9(12). pii: a029454. doi: 10.1101/cshperspect.a029454. Review.

PMID:
28289064
26.

Complex immune correlates of protection in HIV-1 vaccine efficacy trials.

Tomaras GD, Plotkin SA.

Immunol Rev. 2017 Jan;275(1):245-261. doi: 10.1111/imr.12514. Review.

27.

The Importance of Persistence.

Plotkin SA.

Clin Infect Dis. 2016 Dec 1;63(suppl 4):S117-S118. No abstract available.

28.

Need for a New Lyme Disease Vaccine.

Plotkin SA.

N Engl J Med. 2016 Sep 8;375(10):911-3. doi: 10.1056/NEJMp1607146. No abstract available.

PMID:
27602662
29.

Zika as still another argument for a new path to vaccine development.

Plotkin SA.

Clin Microbiol Infect. 2016 Apr;22(4):294-295. doi: 10.1016/j.cmi.2016.03.001. No abstract available.

30.

Global incidence of serogroup B invasive meningococcal disease: a systematic review.

Sridhar S, Greenwood B, Head C, Plotkin SA, Sáfadi MA, Saha S, Taha MK, Tomori O, Gessner BD.

Lancet Infect Dis. 2015 Nov;15(11):1334-46. doi: 10.1016/S1473-3099(15)00217-0. Epub 2015 Oct 6. Review.

PMID:
26453240
31.

Establishing a Global Vaccine-Development Fund.

Plotkin SA, Mahmoud AA, Farrar J.

N Engl J Med. 2015 Jul 23;373(4):297-300. doi: 10.1056/NEJMp1506820. No abstract available.

32.

Increasing Complexity of Vaccine Development.

Plotkin SA.

J Infect Dis. 2015 Jul 15;212 Suppl 1:S12-6. doi: 10.1093/infdis/jiu568.

PMID:
26116724
33.

Pertussis: pertussis control strategies and the options for improving current vaccines.

Plotkin SA.

Expert Rev Vaccines. 2014 Sep;13(9):1071-2. doi: 10.1586/14760584.2014.944166. Epub 2014 Aug 4.

PMID:
25090359
34.

Vaccines: facing complex problems with the promise of immunology.

Plotkin SA, Rees J.

Expert Rev Vaccines. 2014 Aug;13(8):939-41. doi: 10.1586/14760584.2014.934678. Epub 2014 Jun 27.

PMID:
24972860
35.

Toward a human vaccines project.

Koff WC, Gust ID, Plotkin SA.

Nat Immunol. 2014 Jul;15(7):589-92. doi: 10.1038/ni.2871. No abstract available.

PMID:
24940943
36.

Nonneutralizing functional antibodies: a new "old" paradigm for HIV vaccines.

Excler JL, Ake J, Robb ML, Kim JH, Plotkin SA.

Clin Vaccine Immunol. 2014 Aug;21(8):1023-36. doi: 10.1128/CVI.00230-14. Epub 2014 Jun 11. Review.

37.

Problems in vaccine development.

Plotkin SA.

Monoclon Antib Immunodiagn Immunother. 2014 Jun;33(3):166-7. doi: 10.1089/mab.2014.0011. Epub 2014 Apr 1. No abstract available.

PMID:
24689874
38.

Possible options for new pertussis vaccines.

Meade BD, Plotkin SA, Locht C.

J Infect Dis. 2014 Apr 1;209 Suppl 1:S24-7. doi: 10.1093/infdis/jit531. Review.

PMID:
24626868
39.

The pertussis problem.

Plotkin SA.

Clin Infect Dis. 2014 Mar;58(6):830-3. doi: 10.1093/cid/cit934. Epub 2013 Dec 20.

PMID:
24363332
40.

Priorities for CMV vaccine development.

Krause PR, Bialek SR, Boppana SB, Griffiths PD, Laughlin CA, Ljungman P, Mocarski ES, Pass RF, Read JS, Schleiss MR, Plotkin SA.

Vaccine. 2013 Dec 17;32(1):4-10. doi: 10.1016/j.vaccine.2013.09.042. Epub 2013 Oct 13. Review.

41.

A hepatitis B vaccine with a novel adjuvant.

Plotkin SA, Schaffner W.

Vaccine. 2013 Nov 4;31(46):5297-9. doi: 10.1016/j.vaccine.2013.09.019. Epub 2013 Sep 17. No abstract available.

PMID:
24051160
42.

Immunisation against meningococcus B.

Plotkin SA.

Lancet. 2013 Sep 7;382(9895):858. doi: 10.1016/S0140-6736(13)61862-0. No abstract available.

PMID:
24012270
43.

The History of Vaccines.org publishes a book.

Plotkin SA, Youngdahl K.

Vaccine. 2013 Oct 1;31(42):4697. doi: 10.1016/j.vaccine.2013.07.028. Epub 2013 Jul 24. No abstract available.

PMID:
23891500
44.

In memoriam:Hilary Koprowski, 1916-2013.

Plotkin SA.

J Virol. 2013 Aug;87(15):8270-1. doi: 10.1128/JVI.01449-13. Epub 2013 Jun 5. No abstract available.

45.

Accelerating next-generation vaccine development for global disease prevention.

Koff WC, Burton DR, Johnson PR, Walker BD, King CR, Nabel GJ, Ahmed R, Bhan MK, Plotkin SA.

Science. 2013 May 31;340(6136):1232910. doi: 10.1126/science.1232910. Review.

46.

Commentary: Mumps vaccines: do we need a new one?

Plotkin SA.

Pediatr Infect Dis J. 2013 Apr;32(4):381-2. doi: 10.1097/INF.0b013e3182809dda. No abstract available.

PMID:
23552675
47.

Therapeutic vaccines and immunotherapies: current challenges and new frontiers.

Oviedo-Orta E, Plotkin SA, Ulmer JB, Ahmed SS.

Expert Rev Vaccines. 2013 Mar;12(3):243-4. doi: 10.1586/erv.13.29. No abstract available.

PMID:
23496662
48.

Complex correlates of protection after vaccination.

Plotkin SA.

Clin Infect Dis. 2013 May;56(10):1458-65. doi: 10.1093/cid/cit048. Epub 2013 Feb 5.

PMID:
23386629
49.

Measles, mumps, and rubella virus vaccine (M-M-R™II): a review of 32 years of clinical and postmarketing experience.

Lievano F, Galea SA, Thornton M, Wiedmann RT, Manoff SB, Tran TN, Amin MA, Seminack MM, Vagie KA, Dana A, Plotkin SA.

Vaccine. 2012 Nov 6;30(48):6918-26. doi: 10.1016/j.vaccine.2012.08.057. Epub 2012 Sep 7. Review.

PMID:
22959986
50.

Mining the mechanisms of an HIV vaccine.

Plotkin SA, Robinson HL, Davenport MP.

Nat Med. 2012 Jul 6;18(7):1020-1. doi: 10.1038/nm.2858. No abstract available.

PMID:
22772554

Supplemental Content

Loading ...
Support Center